Stocks and Investing
Stocks and Investing
Fri, November 6, 2020
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
Thu, November 5, 2020
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
[ Thu, Nov 05th 2020
] - WOPRAI
Jonathan Chang Maintained (ADAP) at Hold with Decreased Target to $6 on, Nov 5th, 2020
Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Decreased Target from $10 to $6 on, Nov 5th, 2020.
Jonathan, nor any peers, have made any analyst calls on ADAP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources